Target intelligence / Profile preview

CLSPN antisense RNA 1 (CLSPN-AS1)

Target
CLSPN-AS1
Molecular classification
Other, long non-coding RNA, antisense RNA
01

Overview

CLSPN antisense RNA 1 (CLSPN-AS1) is a long non-coding antisense RNA transcribed opposite the CLSPN gene locus. While antisense RNAs can theoretically regulate expression of their sense gene via various mechanisms, there is currently no direct evidence describing the biological functions, disease associations, drug interactions, or clinical relevance of CLSPN-AS1. Nearly all available scientific and therapeutic data focus on the CLSPN gene and its encoded protein Claspin—a checkpoint mediator critical for DNA replication fidelity and cell cycle arrest following DNA damage[1][3][4][6]. Therefore, CLSPN-AS1 is not a recognized direct therapeutic target, and it is potentially an incorrect target designation for most clinical or research applications. For information related to DNA damage response, cell cycle checkpoint, and therapeutic targeting, consult references on CLSPN (Claspin) and its protein product. Key note: If your intention is to target the DNA damage checkpoint pathway, focus on CLSPN and its protein product (Claspin) rather than the antisense RNA[1][3][4][6].

02

Mechanism of action

None known

03

Biological functions

Regulation of CLSPN gene expression (possible, by convention of antisense RNAs, but unconfirmed in available data)
04

Disease associations

Other (no direct evidence for CLSPN-AS1 in disease; all known roles relate to CLSPN)

Beyond the preview

Go deeper on CLSPN antisense RNA 1 (CLSPN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLSPN antisense RNA 1 (CLSPN-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call